Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.22.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jan. 31, 2022
Jul. 31, 2021
Current assets:    
Cash and cash equivalents $ 4,159 $ 13,524
Marketable securities 29,480 29,978
Accounts receivable, net 15,316 10,198
Inventories 13,851 12,652
Prepaid expenses 3,904 4,230
Total current assets 66,710 70,582
Property, plant, and equipment, net 17,527 16,585
Right-of-use assets 15,407 17,020
Goodwill 7,452 7,452
Intangible assets, net 100 244
Other, including restricted cash of $1,000 at January 31, 2022 and $750 at July 31, 2021 1,626 1,808
Total assets 108,822 113,691
Current liabilities:    
Accounts payable – trade 6,860 8,123
Accrued liabilities 15,865 14,301
Current portion of operating lease liabilities 3,187 3,419
Other current liabilities and finance leases short term 236 233
Total current liabilities 26,148 26,076
Finance leases long term and other liabilities 79 115
Operating lease liabilities, non-current 13,199 14,558
Long term debt – net 4,270 4,356
Total liabilities 43,696 45,105
Commitments and contingencies – see Note 12
Stockholders’ equity:    
Preferred Stock, $.01 par value; authorized 25,000,000 shares; no shares issued or outstanding
Common Stock, $.01 par value; authorized 75,000,000 shares; shares issued and outstanding: 48,471,771 at January 31, 2022 and July 31, 2021 485 485
Additional paid-in capital 338,021 337,126
Accumulated deficit (275,351) (270,377)
Accumulated other comprehensive income 1,971 1,352
Total stockholders’ equity 65,126 68,586
Total liabilities and stockholders’ equity $ 108,822 $ 113,691